Chronic cough, defined as a cough lasting more than eight weeks, poses a diagnostic challenge in clinical practice. Despite its prevalence, the underlying causes often remain elusive. This article aims to provide a comprehensive approach to diagnosing and managing chronic cough.
A thorough patient history and physical examination are paramount. Key factors include the duration and quality of the cough, associated symptoms, and exposure to potential triggers. Initial investigations should focus on common causes: upper airway cough syndrome (UACS), gastroesophageal reflux disease (GERD), and asthma. Chest radiography and spirometry are often beneficial.
Management should be etiology-specific. For UACS, first-line treatment includes nasal corticosteroids and antihistamines. GERD-related cough may respond to proton pump inhibitors. Inhaled corticosteroids are the cornerstone of asthma management. If the cough persists despite appropriate treatment, consider less common etiologies such as non-asthmatic eosinophilic bronchitis, chronic bronchitis, and bronchiectasis.
For refractory cases, a multidisciplinary approach is recommended. Collaboration between pulmonologists, gastroenterologists, allergists, and otolaryngologists can provide a holistic patient assessment and foster a more targeted therapeutic strategy. Speech-language pathologists can also play a crucial role in managing cough hypersensitivity syndrome.
Emerging diagnostic tools, such as impulse oscillometry and bronchial provocation tests, may help identify subtle abnormalities in lung function. Further research is needed to understand the pathophysiology of chronic cough better and develop more effective treatments.
Chronic cough is a complex clinical entity that requires a comprehensive, systematic approach for effective diagnosis and management. A multidisciplinary team can provide invaluable insights for challenging cases. As our understanding of chronic cough continues to evolve, so too will our diagnostic capabilities and therapeutic strategies.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation